Recent trends in the immunopathogenesis of tuberculosis by Ramanathan, V D & Shakila, H
J. Immunol. Immunopathol. 2004. 6(S-1): 7-12 
Society for Immunology & Immunopathology, Pantnagar. 
Recent trends in the immunopathogenesis of tuberculosis 
*VD Ramanathan and H Shakila 
Department of Pathology, 
Tuberculosis Research Centre, 
Indian Council of Medical Research, 
Mayor V.R.Ramanathan Saalai, Chetpet, 
Chennai - 600 031. 
*Corresponding Author 
email: vdrnathan@yahoo.com 
PREAMBLE 
Tuberculosis kills about 500,000 Indians every year, ie, one person every minute. For every patient who dies of 
the disease, there are at least two individuals who develop disability. Further, the advent of infection by the human 
immunodeficiency virus and drug resistant forms of Mycobacterium tuberculosis have made the management and 
control of tuberculosis more difficult. Although the genome of M. tuberculosis has been sequenced, diagnosis of the 
infectious sputum positive case is straightforward, simple and inexpensive and effective short course chemotherapy 
is available, morbidity and mortality due to the disease have not appreciably decreased. 
Among the several reasons cited for this failure are the inadequacy of the BCG vaccine in preventing post 
primary tuberculosis and the relatively long duration (six months) of chemotherapy which encourages irregularity and 
incomplete treatment. Furthermore, two more aspects which deserve consideration are a) lack of appropriate tests to 
identify the individual who is likely to develop clinical illness and b) disability caused by the disease process. 
This presentation will limit itself to two major areas of the immunopathology of the disease. These are a) host 
immune mechanisms underlying the varied clinical and pathological manifestations and b) events that lead to tissue 
damage and disability 
HOST IMMUNE MECHANISMS 
The histopathology of tuberculosis presents a pleomorphic picture ranging from a well-organised, non-necrotic, 
epithelioid cell granuloma to a poorly-organised granuloma with necrosis and macrophages with very few epithelioid 
cells (Ramanathan et al., 1999). Further, it is known that the predominant histological form also varies from organ to 
organ. While necrosis is common in pulmonary and lymphoidal lesions, it is rare in the skin especially in verrucosa 
cutis. 
The immunopathology of tuberculosis is best understood by following its natural history. The evolution of the 
disease when the organism enters a host for the first time is different from that when it invades subsequently. The 
sequence of events following the first infection leads to what is known as the primary complex. Post primary tubercu- 
losis is the term given to the disease when an individual comes down with the disease subsequently. 
Primary complex 
The first infection with tuberculosis occurs usually in childhood especially in our country where the disease is 
endemic. In a majority of cases, the primary complex involves areas in the lung and the draining hilar lymph nodes. 
Occasionally, this may be seen in the tonsils and the cervical lymph nodes or the intestine and the mesenteric lymph 
nodes. Very rarely, this can occur in the skin in the form of a tuberculous chancre. 
The initial infection in the lung occurs by deposition of the bacilli in the acini at one or more places. M.tuberculosis 
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encounters the complement system initially which it activates (Schlesinger et al., 1990). A consequence of this is an 
exudative lesion with local oedema and recruitment of neutrophils which phagocytose the bacilli though this does not 
lead to killing of the organisms. Instead. the bacilli multiply and monocytes are recruited into the lesion now and the 
infection proceeds to the next granulomatous phase with infiltration additionally by T lymphocytes also. At this stage 
gd T cells appear to play a prominent role (Dieli et al., 2000). 
Although this primary or Ghon’s focus can occur anywhere in the lung, it is more often seen in a lower lobe 
where the ventilation is greater. Pathogenetically, this results in a tuberculous pneumonia with oedema and deposi- 
tion of fibrin along with the monocytes. Bacilli or bacilli-laden phagocytes then reach the draining lymph node via 
lympahtics and a secondary focus arises. The primary focus in the lung usually remains small and develops central 
caseation and transforms into a typical granuloma. 
During the early evolution of the primary complex, spread along the lymphatics may extend up to the superior 
mediastinal nodes or even to those in the upper abdomen. From the lymphatics, a few bacilli may escape into the 
venous system from where they filter into the organs of the reticulo endothelial system viz. the spleen, liver or bone 
marrow. Even the lung can be a secondary focus through haematogenous spread and this is seen more often in the 
apical areas of the lung and is known as the Simon’s focus. 
Over a period ranging from several weeks to a few months, the lesion becomes encapsulated. Eventually heal- 
ing occurs by fibrosis with the area of caseation becoming calcified or rarely even ossified. The secondary lymph 
node focus also follows the same course although the lesion may be bigger and healing slower than the primary 
focus. 
Approximately about six to eight weeks after the initial infection, antigen reactive ab T lymphocytes appear in 
the lesion and this is characterised systemically by the development of cutaneous hypersensitivity to PPD and the 
Mantoux test becomes positive. At this stage, the host develops the ability to kill the organisms. However, a few bacilli 
may remain alive a in a metabolically inactive state in some of the caseous areas for months, years or even decades 
becoming activated at any time by a breakdown in immunity. 
Progressive primary complex 
The course of events described above, namely, a transient growth of the bacilli and their spread to lymph nodes 
flowed by encapsulation of the lesion and healing occurs in a very large proportion of the infected individuals. How- 
ever, in about 10% of the patients, owing to a combination of increased bacterial virulence, increased hypersensitivity 
and lowered resistance to the infection, instead of healing, the lesion progresses into a more serious form. 
The caseous material may liquefy and live bacilli may become disseminated through the bronchi to other regions 
of the lung or even to the opposite lung. Often, this is seen when the enlarged hilar node erodes a bronchus and 
discharges the bacilli. If hypersensitivity against the organisms is marked, further destruction of normal lung and 
dissemination of the bacilli are inevitable. In a study in children suffering from progressive primary complex, it has 
been shown that the production of IFN- g by their peripheral blood lymphocytes was significantly greater than normal 
children (Swaminathan et al., 1999). This probably indicates that though these children are able to react by producing 
IFN- g, either it is not enough or additional factor(s) may be required to contain the illness. 
Instead of the erosion of the bronchus, if large numbers of organisms are discharged into a blood vessel, 
miliary tuberculosis results with multiple granulomata in the lung, liver, spleen, kidneys, brain and bone marrow. 
Usually, the Mantoux test is negative in these patients. 
Post primary tuberculosis 
Post primary form of tuberculosis is the predominant type of disease seen in our country since a majority of the 
individuals would have been exposed to the tubercle bacilli in their childhood itself. 
In most cases, post primary tuberculosis is first detected in the subapical region of one or both lungs, probably 
caused by spread of viable bacilli from a Simon’s focus. The disease arises as a small tuberculous pneumonia. At this 
stage, the lesion is characterised by exudation of fibrin and recruitment of neutrophils and monocytes in the alveoli. 
As mentioned earlier, the recruitment of neutrophils at an early stage can be attributed to activation of complement 
and release of C5a, a potent neutrophil chemotactic factor. However, experiments in mice have shown that a persist- 
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ent neutrophilic influx may be attributed to T lymphocytes (Appelberg, 1992). 
The lesion, which is predominantly intra alveolar at this stage, may. still heal spontaneously. On the other hand, 
it may progress slowly with well-developed epithelioid cell granuloma and central area of caseation. Alternatively, 
some of the granulomata may heal while others might develop in the same organ. Usually, however, the lesion 
undergoes extensive necrosis and liquefaction and then sloughing occur, especially through a patent bronchus, 
giving rise to a cavity. Viable M.tuberculosis is freely excreted through the sputum into the environment in this produc- 
tive stage of the disease. 
The formation of cavity is a major event in the natural history of tuberculosis. Since the cavity opens out into the 
airway, the bacteria proliferate more rapidly due to higher oxygen availability. Further, as the cavity communicates into 
the bronchial tree, bacilli can spread to the other parts of the lungs on the one hand and on the other, can be excreted 
out into the environment and thereby infect fresh individuals in the community. 
Depending on the number of organisms being released from the cavity, lesions of varying sizes are produced 
elsewhere in the lung. Tuberculous cavities are of great pathogenic significance for two more reasons. The first is the 
formation of aneurysms of the arteries that cross the cavity. Although most of the vessels become fibrosed, in some, 
the destruction of the wall leads to the formation of aneurysms which then become vulnerable any time to cause 
haemoptysis and even fatal haemorrhage. The second reason is that widespread cavity formation destroys a large 
mass of the lung and when the disease is treated with anti tuberculous drugs, it heals with extensive fibrosis leading 
to considerable disability even after the primary process of the disease is controlled. 
IMMUNOLOGICAL CORRELATES OF THE PATHOLOGICAL AND CLINICAL MANIFESTIONS OF TUBERCULOSIS 
The two main outcomes of the interaction of M. tuberculosis with human beings, protection and immunopathology 
(which can eventual!y lead to disability or death) can be understood by looking at the immunological correlates of the 
various manifestations. Our current knowledge is derived from two major approaches: 1) studies on experimental 
infection in laboratory animals, especially mice where the disease can be dissected out using gene disrupted mice 
and 2) correlative studies in natural human infections where the immunological response patterns of peripheral blood 
leucocytes and tissue pathology can be undertaken. 
There are obvious advantages and disadvantages when looking at each of the above mentioned approaches 
separately. For example, it is well known that the mouse is a very poor model to study human tuberculosis and guinea 
pigs are more appropriate (Mc Murray et al., 1996). However, lack of gene disrupted guinea pigs and paucity of 
immunological reagents against guinea pig host cells and products have hindered a wide spread use of this species 
to understand the host response to M.tuberculosis. Thus-caution must be exercised while extrapolating mouse data 
to human tuberculosis. On the other hand, the disadvantages while studying human disease are a) the in vivo immu- 
nological correlates of an evolving lesion cannot be studied and b) it is often difficult to get the affected tissues to 
examine the in situ immunological parameters and immunological profiling of peripheral blood cells may not be 
representative of what goes on at the site of lesion. However, occasionally, ‘experiments of nature’ have shown the 
crucial role of IFN- g (Jouanguy etal., 1996; Newport et al., 1996) and IL-12 (Altare etal., 1998; de Jong et al., 1998). 
In addition, the vital importance of the CD4 T cells in controlling M.tuberculosis has been amply demonstrated in HIV 
infected individuals. 
Notwithstanding the obvious disadvantages of these two approaches, considerable progress has been made in 
our understanding the immunological basis of the disease and will be reviewed in the following section. 
Protection 
While initial complement activation and subsequent mediation of phagocytosis through the various complement 
receptors are important in the establishment of the infection, interaction with the complement system does not lead to 
killing of mycobacteria (Schlesinger et al., 1990). Early in the infection, gd T cells appear to play a role in killing 
infected cells and the bacterial by the granule pathway (Dieli et al., 2000). These cells decline after treatment sug- 
gesting that probably these are driven by the presence of viable tubercle bacilli. 
It is presently held that anti tuberculous immunity is mainly mediated by T lymphocytes belonging to CD4, CD8 
and gd subsets (Stenger and Modlin, 1999). As has been shown through a number of animal experiments and data 
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from human tuberculosis (Reviewed in Rook and Hernandez-Pando, 1996; Rook and Zumla, 2001), Type 1 response 
appears to be vital for protective immunity in tuberculosis. This involves the release of IL-12 from antigen presenting 
cells and IL-2 and IFN- g from T lymphocytes. Apart from CD 4 cells, CD 8 cells (Cho et al., 2000; Pathan et al., 2000) 
and CD 68 bearing macrophages (Fenhalls et al.. 2000) have also been shown to produce IFN- g. It is believed that 
apart from these cytokines. the other pro inflammatory cytokine TNF- a also is critical in inducing protective immunity 
in tuberculosis (Kindler et al., 1989; Hernandez-Pando et al., 1997). 
Immunopathology and tissue damage 
The ideal response of a host to M.tuberculosis should be such that it is able to contain and destroy the bacilli 
without damaging the host tissue. This could be the case in the majority of individuals who have been infected but 
have not developed clinical disease. However, in all patients who have clinical disease, it can be safely assumed that 
this ideal response has not taken place. A major cause of the morbidity can be attributed to the nature of host 
response itself. 
A number of cytokines appear to be important in producing the clinical manifestations of the disease. For exam- 
ple, it is known that IL-1 is responsible for the fever while TNF- a causes loss of appetite and loss of weight seen in 
tuberculosis. Similarly, IL-4, a cytokine associated with Type 2 response appears to play a role in inducing cavitary 
tuberculosis (van Cravel et al., 2000). Additionally, murine experiments have shown that IL-4 is important for the 
toxicity of TNF- a and the fibrogenic effects of TGF-B (Hernandez-Pando et al., 2004). 
In studies involving experimental tuberculosis in the guinea pig it was shown that in the initial phase of infection 
there was a gross destruction of the affected tissue followed by fibrosis as indicated by an increase in the content of 
hydroxyproline (Jayasankar et al., 1999). Similarly, in human cutaneous tuberculosis, it was shown that the TGF- b 
and collagen which were elevated in the active disease regressed with chemotherapy (Jayasankar et al., 2002) thus 
demonstrating the importance of fibrogenic cytokines. 
The role of B cells in tuberculosis 
Traditionally, B lymphocytes and antibodies have been thought to be of marginal significance in tuberculosis. 
However, the data currently available suggests a more complex picture. We have seen the presence of large num- 
bers of B lymphocytes (even up to 20% of the lymphocyte population in the granuloma) in cutaneous tuberculosis 
(Shakila et al., manuscript under preparation). Similarly, evidence from animal studies using B cell-deficient mice has 
indicated that these cells could play an active role in containing the spread of the tubercle bacilli (Bosio et al., 2000). 
Further, since B cells are potent antigen presenting cells, these could be of relevance in inducing the appropriate T 
cell response also. Additionally, in situ antibody production (Ridley and Ridley, 1986) especially in necrotic areas 
implies that these could be involved in immunopathology, It has been shown that in tuberculous lymph adenitis that 
plasma cells were more numerous in necrotic lesions compared to non necrotic ones (Ramanathan et al., 1999). 
STRESS AND IMMUNE RESPONSE IN TUBERCULOSIS 
Early in the last century it was shown that phagocytes from individuals undergoing emotional stress were able 
to phagocytose less number of tubercle bacilli (Khansari et al., 1990). It is well known that stress releases glucocorticoid 
hormones and these are capable of suppressing subsequent immune response (Rook and Zumla, 2001). These 
appear to act by a switch over to Type 2 cytokine response (Ramirez et al., 1996) by increasing the production of IL- 
10 and reducing the release of IL-12 (Visser et al., 1998) and down regulating the antimycobacterial effects of 
macrophages (Rook et al., 1987). Thus, any efforts to understand the immunology and pathology of tuberculosis in 
human beings will have to include a systematic study of the effects of stress in precipitating latent tuberculosis - an 
area sadly neglected so far. 
CONCLUDING REMARKS 
It is clear from the foregoing that immuno protection and immuno pathology are finely balanced by a complex 
interplay of cells and cytokines (Fig 2). Further, a clear understanding of these factors would help answer the question 
as to why only a small fraction of infected individuals in an endemic area actually come down with the disease. 
Additionally, efforts are needed to institute adequate measures to prevent and revert the tissue damage inflicted by 
host responses. A major consequence of tissue damage is the permanent disability that a large number of patients 
suffer from which adds to the gross post treatment morbidity in tuberculosis. It is certainly clear that the issues 
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mentioned above need to be addressed to pave the way for devising early diagnostic tests and developing suitable 
strategies for prevention of this 'captain of all men of death'. 
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